Barbara Ensoli

18.8k total citations · 2 hit papers
249 papers, 13.8k citations indexed

About

Barbara Ensoli is a scholar working on Virology, Immunology and Oncology. According to data from OpenAlex, Barbara Ensoli has authored 249 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Virology, 103 papers in Immunology and 83 papers in Oncology. Recurrent topics in Barbara Ensoli's work include HIV Research and Treatment (126 papers), Viral-associated cancers and disorders (78 papers) and Immune Cell Function and Interaction (51 papers). Barbara Ensoli is often cited by papers focused on HIV Research and Treatment (126 papers), Viral-associated cancers and disorders (78 papers) and Immune Cell Function and Interaction (51 papers). Barbara Ensoli collaborates with scholars based in Italy, United States and Germany. Barbara Ensoli's co-authors include Giovanni Barillari, Robert C. Gallo, Paolo Monini, Aurelio Cafaro, Luigi Buonaguro, Valeria Fiorelli, R Gendelman, S. Zaki Salahuddin, Michael Stürzl and Flossie Wong‐Staal and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Barbara Ensoli

247 papers receiving 13.5k citations

Hit Papers

Tat protein of HIV-1 stim... 1990 2026 2002 2014 1990 1993 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Barbara Ensoli 5.6k 5.4k 4.1k 3.9k 3.8k 249 13.8k
Peter C. L. Beverley 3.6k 0.7× 2.4k 0.4× 11.8k 2.9× 3.3k 0.8× 3.8k 1.0× 297 19.0k
Stephen C. Peiper 5.7k 1.0× 4.2k 0.8× 6.6k 1.6× 1.2k 0.3× 4.3k 1.1× 178 14.1k
Thomas F. Schulz 1.4k 0.3× 8.5k 1.6× 2.7k 0.7× 6.8k 1.7× 1.6k 0.4× 358 14.1k
Ronald T. Mitsuyasu 4.2k 0.8× 3.0k 0.6× 3.3k 0.8× 2.4k 0.6× 1.8k 0.5× 178 10.3k
Derya Unutmaz 6.1k 1.1× 2.5k 0.5× 11.3k 2.8× 2.3k 0.6× 3.6k 1.0× 141 18.1k
René A. W. van Lier 1.7k 0.3× 4.2k 0.8× 16.4k 4.0× 4.4k 1.1× 3.3k 0.9× 350 22.7k
Joshua Μ. Farber 2.7k 0.5× 4.7k 0.9× 8.9k 2.2× 1.8k 0.5× 2.7k 0.7× 135 14.1k
Louis J. Picker 8.0k 1.4× 3.4k 0.6× 16.9k 4.1× 6.5k 1.7× 4.7k 1.2× 199 29.2k
Peter Biberfeld 939 0.2× 4.4k 0.8× 3.1k 0.8× 3.5k 0.9× 2.0k 0.5× 263 10.8k
Walter Newman 4.1k 0.7× 2.6k 0.5× 9.0k 2.2× 1.4k 0.4× 3.1k 0.8× 108 16.3k

Countries citing papers authored by Barbara Ensoli

Since Specialization
Citations

This map shows the geographic impact of Barbara Ensoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ensoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ensoli more than expected).

Fields of papers citing papers by Barbara Ensoli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ensoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ensoli. The network helps show where Barbara Ensoli may publish in the future.

Co-authorship network of co-authors of Barbara Ensoli

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ensoli. A scholar is included among the top collaborators of Barbara Ensoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ensoli. Barbara Ensoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sgadari, Cecilia, Orietta Picconi, Antonella Tripiciano, et al.. (2024). Clinical Efficacy of the HIV Protease Inhibitor Indinavir in Combination with Chemotherapy for Advanced Classic Kaposi Sarcoma Treatment: A Single-Arm, Phase II Trial in the Elderly. Cancer Research Communications. 4(8). 2112–2122. 2 indexed citations
2.
Cafaro, Aurelio, Ivan Schietroma, Leonardo Sernicola, et al.. (2024). Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis. International Journal of Molecular Sciences. 25(3). 1704–1704. 15 indexed citations
3.
Qiu, Yaqi, Federica Maione, Claudia Meda, et al.. (2020). HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction. Molecular Cancer Therapeutics. 19(12). 2476–2489. 10 indexed citations
4.
Tavoschi, Lara, Giuseppe D’Avenio, Simone Becattini, et al.. (2012). Characterization of variable regions of the Gp120 protein from HIV-1 subtype C virus variants obtained from individuals at different disease stages in Sub-Saharan Africa. Journal of AIDS & Clinical Research. 3. 1 indexed citations
5.
Papathanasopoulos, Maria A., Eftyhia Vardas, Carole L. Wallis, et al.. (2010). Characterization of HIV Type 1 Genetic Diversity Among South African Participants Enrolled in the AIDS Vaccine Integrated Project (AVIP) Study. AIDS Research and Human Retroviruses. 26(6). 705–709. 10 indexed citations
6.
Borsetti, Alessândra, Silvia Baroncelli, Maria Teresa Maggiorella, et al.. (2009). Containment of Infection in Tat Vaccinated Monkeys After Rechallenge with a Higher Dose of SHIV89.6P cy243. Viral Immunology. 22(2). 117–124. 11 indexed citations
7.
Florese, Ruth H., Thorsten Demberg, Peng Xiao, et al.. (2009). Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines. The Journal of Immunology. 182(6). 3718–3727. 99 indexed citations
8.
Fanales‐Belasio, Emanuele, Sonia Moretti, Valeria Fiorelli, et al.. (2009). HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection. The Journal of Immunology. 182(5). 2888–2897. 41 indexed citations
9.
Walwema, Richard, Anna Cappelletti, Stefano Buttò, et al.. (2008). Subtype Assignment and Phylogenetic Analysis of HIV Type 1 Strains in Patients from Swaziland. AIDS Research and Human Retroviruses. 24(2). 323–325. 8 indexed citations
10.
Buffa, Viviana, Donatella Negri, Pasqualina Leone, et al.. (2006). Evaluation of a Self-Inactivating Lentiviral Vector Expressing Simian Immunodeficiency Virus Gag for Induction of Specific Immune Responses in Vitro and in Vivo. Viral Immunology. 19(4). 690–701. 28 indexed citations
11.
Biassoni, Roberto, Manuela Fogli, Claudia Cantoni, et al.. (2005). Molecular and Functional Characterization of NKG2D, NKp80, and NKG2C Triggering NK Cell Receptors in Rhesus and Cynomolgus Macaques: Monitoring of NK Cell Function during Simian HIV Infection. The Journal of Immunology. 174(9). 5695–5705. 36 indexed citations
12.
Ridolfi, Barbara, Fausto Titti, Maria Teresa Maggiorella, et al.. (2004). Infection of a Simian B Cell Line by Human and Simian Immunodeficiency Viruses. AIDS Research and Human Retroviruses. 20(7). 723–732. 3 indexed citations
13.
Alessandri, Giulio, Simona Fiorentini, Stefano Licenziati, et al.. (2003). CD8 + CD28 - T Lymphocytes from HIV-1-Infected Patients Secrete Factors That Induce Endothelial Cell Proliferation and Acquisition of Kaposi's Sarcoma Cell Features. Journal of Interferon & Cytokine Research. 23(9). 523–531. 5 indexed citations
14.
Lubeseder–Martellato, Clara, Eric Guenzi, Elisabeth Naschberger, et al.. (2002). Guanylate-Binding Protein-1 Expression Is Selectively Induced by Inflammatory Cytokines and Is an Activation Marker of Endothelial Cells during Inflammatory Diseases. American Journal Of Pathology. 161(5). 1749–1759. 126 indexed citations
15.
Battistini, Angela, Giulia Marsili, Marco Sgarbanti, Barbara Ensoli, & John Hiscott. (2002). Review: IRF Regulation of HIV-1 Long Terminal Repeat Activity. Journal of Interferon & Cytokine Research. 22(1). 27–37. 42 indexed citations
16.
Fanales‐Belasio, Emanuele, Sonia Moretti, Filomena Nappi, et al.. (2002). Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses. The Journal of Immunology. 168(1). 197–206. 123 indexed citations
17.
Ascherl, Gudrun, Cecilia Sgadari, Roberto Bugarini, et al.. (2001). Serum Concentrations of Fibroblast Growth Factor 2 Are Increased in HIV Type 1-Infected Patients and Inversely Related to Survival Probability. AIDS Research and Human Retroviruses. 17(11). 1035–1039. 23 indexed citations
18.
Ensoli, Barbara, P D Markham, Giovanni Barillari, et al.. (1994). Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.. Journal of Clinical Investigation. 94(5). 1736–1746. 106 indexed citations
19.
Ensoli, Barbara, Giovanni Barillari, & Luigi Buonaguro. (1992). Role of cytokines from activated T cells and HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi’s sarcoma.. AIDS Research and Human Retroviruses. 8(5). 876–876. 2 indexed citations
20.
Barillari, Giovanni, Luigi Buonaguro, R C Gallo, & Barbara Ensoli. (1990). Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma.. Cineca Institutional Research Information System (Tor Vergata University). 9(4). 582–582. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026